Wendy Bulow
Physician Assistant · Colorado Springs, CONPI 1376579540
Payments from drug & device makers
Across 288 payments — averaging $23.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$973
- Takeda Pharmaceuticals U.S.A., Inc.$921
- Sanofi$572
- Genentech USA, Inc.$452
- Amgen$441
- plus $1K from 14 others
What the payments were for
- Consulting fees$230%
- Food & beverage$6,844100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 57 | $2,092 |
| GSK | 64 | $973 |
| Takeda Pharmaceuticals U.S.A., Inc. | 51 | $921 |
| Sanofi | 22 | $572 |
| Genentech USA, Inc. | 22 | $452 |
| Amgen | 12 | $441 |
| Regeneron Healthcare Solutions, Inc. | 18 | $381 |
| Novartis | 14 | $260 |
| CSL Behring | 7 | $201 |
| Biocryst US Sales Co., LLC | 5 | $157 |
| AbbVie | 3 | $140 |
| Grifols USA, LLC | 3 | $73 |
| Ionis Pharmaceuticals, Inc. | 2 | $45 |
| Optinose US, Inc. | 2 | $40 |
| Greer Laboratories, Inc. | 1 | $33 |
| Pfizer | 1 | $24 |
| ADMA Biomanufacturing LLC | 1 | $23 |
| Octapharma USA, Inc. | 1 | $20 |
| Merck | 1 | $16 |
| Organon | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,867 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 62 | $50,541 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $9,886 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $7,202 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $6,091 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 26 | $6,074 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,103 |
| Azelastine Hcl | 35 | $1,000 |
| Montelukast Sodium | 78 | $890 |
| Ventolin HfaAlbuterol Sulfate | 13 | $691 |
| Fluticasone Propionate | 22 | $384 |
| Ipratropium Bromide | 12 | $219 |
| Omeprazole | 13 | $127 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $973 | $57,74473 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,092 | $15,97732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Colorado Springs
- Miyoko GreenColorado Springs$16K
- Toni BoykoColorado Springs$12K
- Dominique SwainColorado Springs$10K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.